Company Overview and News

1
BPS Technology calls for halt as shareholders vote

2017-11-03 proactiveinvestors.com.au
Everest MB Pty Ltd holds an 11% stake, and has outlined its intention to move resolutions for the removal of each of Iain Dunstan, Peter Clare, Andrew Daniele Frances Pipolo and Anthony Jude Lally.
Upvote Downvote

 
BRIEF-BPS Technology says unit signed a marketing cooperation agreement with Alipay

2017-09-18 reuters
* BPS Technology - Expected that 150 gold coast merchants will have Alipay access over next quarter & 1,200 merchants on coast, Melbourne and Sydney this FY Source text for Eikon: Further company coverage:
Upvote Downvote

 
BPS Technology Ltd expands U.S. network by 50% in one month

2016-09-26 proactiveinvestors.com.au
BPS Technology Ltd (ASX:BPS) continues to execute its Bartercard growth strategy in North America, opening six new franchises across the U.S. in a record-breaking month. The company’s U.S. business network has now grown to 18 franchises, with a presence in eight states which represent 25% of U.S. economic output. Bartercard is a B2B digital currency tool that allows business owners to barter or trade their goods and services between one another without the use of cash.
Upvote Downvote

 
BPS Technology Ltd pounces on acquisition

2016-08-12 proactiveinvestors.com.au
BPS Technology Ltd (ASX:BPS) will acquire Entertainment Publications Australia and New Zealand, a business-to-consumer deals platform which produces the Entertainment Book and the Entertainment Digital Membership. The acquisition will provide a fairly immediate financial benefit, and will boost BPS’ growth profile with FY17E pro forma revenue growth of 118% and FY17E pro forma EBITDA growth of 49%.
Upvote Downvote

 
BPS Technology Ltd gets Aussie health foods company onto Alibaba web portal

2016-06-17 proactiveinvestors.com.au
BPS Technology Ltd (ASX:BPS) has snared an agreement for Australian health food company Morlife, based on the Gold Coast to sell its health foods on Alibaba’s (NYSE:BABA) 1688.com trade portal. Morlife, an Australian manufacturer of functional foods, is the first of BPS's merchants to gain access to Alibaba’s sales and web portal. The deal is a coup for Morlife as it gains access to the world’s fastest-growing health-food market, This is part of an agreement that BPS inked with listed online billing provider SmartTrans Holdings Ltd (ASX: SMA) to promote and sell products in China via e-commerce giant Alibaba.
Upvote Downvote

 
SmartTrans Holdings Ltd wins China Ministry of Commerce award

2016-05-31 proactiveinvestors.com.au
SmartTrans Holdings Ltd (ASX:SMA) is a technology company with a mobile billing and payments platform in China.
Upvote Downvote

 
BPS Technology Ltd eyes robust growth in B2B barter tool

2016-05-27 proactiveinvestors.com.au
BPS Technology Ltd (ASX:BPS) has expanded the reach of its Bartercard operations in North America with the sale of three new franchises in Tennessee, California and Georgia. Bartercard is a B2B digital currency tool that allows business owners to barter or trade their goods and services between one another without the use of cash. BPS is a profitable company, earning a net profit after tax of $3.5 million in 1H2016, up 7.
Upvote Downvote

 
BPS Dividend payment

2016-04-22 asx.com.au
Upvote Downvote

 
Appendix 3B Correction

2016-04-08 asx.com.au
Upvote Downvote

 
Appendix 3B

2016-04-07 asx.com.au
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

12h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...